This effect could have therapeutic implications for obesity-related inflammation because COX-2-derived prostanoids, mainly prostaglandin E2 (PGE2), play a significant role in mediating macrophage infiltration and inflammation in the visceral fat and the development of AT and systemic insulin resistance and fatty liver [85,86]. This evidence concerns the gene INS and obesity disorder.